Compliance Certificate For The Period Ended March 31, 2018
Disclosure under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2017 is attached24-04-2018
24-04-2018
Board Meeting-Outcome of Board Meeting
Pursuant to Regulation 30 and any other applicable provisions of SEBI LODR Regulations, please note that the Board of Directors of the Aspira Pathlab & Diagnostics Limited ('Company') at its meeting held today, 21st April 2018, has, subject to approval of shareholders of the Company in general meeting , approved as per attached sheet.21-04-2018
Board Meeting On 21St April, 2018
Pursuant to Regulation 29 (1) (d) read with Regulation 29(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, 21st April, 2018 at 3 pm to consider, inter alia, the following matters: 1. To increase authorized capital and alter Memorandum and Article of Association of the Company....18-04-2018
Shareholding for the Period Ended March 31, 2018
Aspira Pathlab & Diagnostics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here17-04-2018
Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Dr. Chander Puri Designation :- Director16-04-2018
Announcement under Regulation 30 (LODR)-Public Announcement-Delisting
We enclose a copy of approval letter received from Metropolitan Stock Exchange of India Limited ("MSE") Informing that the Company will be delisted from the MSE with effect from April 12, 201830-03-2018